SNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™
CRVO: $150 Million Financing Strengthens Balance Sheet; Topline Data for Phase 2b Trial in 4Q24
Sadot Group Potential Profitable Growth Going Forward Supports Price Target of $3.50.
IR-Med's Potential for Profitable Growth in Coming Years Supports Price Target of $3.00
HTCR: HeartCore Announces Sale of $9.0 Million in Go IPO Client Warrants
BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
Sponsored
PNDHF: Insider Participation in Private Placement Underscores Management's Confidence in Company Prospects
FRXIF: A Stock On the Cusp of Catching On Fire
FRXIF: A Stock On the Cusp of Catching On Fire
CLMEF: An Energy Company with an Enticing Yield
VSQTF: Q2 Report at Victory Square Shows Rapid Growth at IV Hydreight and XR Immersive
GBLI: INITIATION: Smallcap specialty property & casualty insurer entering a new and focused growth phase. The company operates in specialty areas primarily in excess and surplus lines.
IFBD: New growth strategy leading to expanding customer base
MCVT: An Old-Fashioned Money Maker in Volatile Times
MCVT: An Old-Fashioned Money Maker in Volatile Times
ALLR: A Precision Undertaking
ATE.TO: Plans on Track for Acute Pain Program for Otenaproxesul…
CPKF: Raising EPS Estimates for 2022 and 2023
SOBR: Advanced technology company disrupting the alcohol management industry by focusing on preventive solutions instead of reactive processes.
ACOGF: Bioequivalence Complete